ReeAishw

Aptecht- Rekha Jhunjhunwala Portfolio Stock.

Long
NSE:APTECHT   APTECH LTD
Hie, In this portfolio specific series, we talk about some stock which top Indian investors hold.
In limelight today we have Rekha jhunjhunwala. Her net worth is over Rs . 3,861.1 Cr .

She is the co-owner of the company 'RARE Enterprises' with her husband Rakesh jhunjhunwala. The name of the company is derived from the initials of the joint owners,'Ra' from Rakesh and 'Re' for Rekha. It seems like the company name is the only place where is she given equal opportunity of merit whereas on Google and Wikipedia they have not given her any digital space of her own. I guess history will see down, yet another mysterious woman whose story could have benefited thousands if not millions, go undiscovered and unexplored. Holding% - 11.28%

Aptech Ltd. is a holding company, which engages in the business of education training and assessment solution services. It operates through Retail, and Non-retail segments. The Retail segment consists of network of vocational, and pre-school learning centres under various brands as Aptech, primarily run with a franchise model.

*Increasing profits every quarter for the past 3 quarters
*Growth in Net Profit with increasing Profit Margin (QoQ)
*Companies with 10% increase in share price over three months, with rising net profit growth

*Company with negative growth and promoters decreasing shareholding QoQ
*Inefficient use of assets to generate profits - ROA declining in the last 2 years

for more you can check the stock out on trendlyne.com/fundamentals/financials/95/ APTECHT /aptech-ltd/

Sources credit:
Trendlyne

If you like the analysis, do leave a like and follow for more such content coming up.
The analysis is my POV , in no way it is a buy-sell recommendation. Hope you got bucks in your pocket to consult a financial advisor before investing :P :)

HAPPY TRADING!!!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.